Cytokeratin 19 antibody (C-Term)
Quick Overview for Cytokeratin 19 antibody (C-Term) (ABIN965902)
Target
See all Cytokeratin 19 (KRT19) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 379-392, C-Term
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminal of human CK19 (379-392aa), identical to the related mouse and rat sequence.
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Reconstitution
- 0.2ml of distilled water will yield a concentration of 500µg/ml.
-
Buffer
- Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4
-
Preservative
- Thimerosal (Merthiolate), Sodium azide
-
Storage
- -20 °C
-
-
-
: "New consensus nomenclature for mammalian keratins." in: The Journal of cell biology, Vol. 174, Issue 2, pp. 169-74, (2006) (PubMed).
-
-
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Alternative Name
- CK19
-
Background
- Cytokeratin-19 (CK-19) or keratin-19 (K19) is a protein that in humans is encoded by the KRT19 gene. Keratin 19 is a type I keratin. Keratin 19 is a member of the keratin family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains. Unlike its related family members, this smallest known acidic cytokeratin is not paired with a basic cytokeratin in epithelial cells. It is specifically expressed in the periderm, the transiently superficial layer that envelops the developing epidermis. The type I cytokeratins are clustered in a region of chromosome 17q12-q21.
Target
-